Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on Proposed Rule to Implement…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the proposed Outbound Investment Security Program (OISP) rule:"The Administration is correct that…
Learn more
BIO Statement on the FDA’s ‘Fit-for-Purpose Rare…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the FDA’s ‘Fit-for-Purpose Rare Disease Framework Initiative.’“Today’s announcement is an important step…
Learn more
BIO Statement on Finalization of the Globe Model
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on the finalization of the GLOBE model.“Biotechnology is one of America's greatest strengths, delivering…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Statement on MedPAC Vote
April 7, 2017
Washington, DC (April 6, 2017) – The Biotechnology Innovation Organization (BIO) issued the following statement regarding today's Medicare Payment Advisory Commission (MedPAC) vote:
Congresswoman Sinema Honored as BIO Legislator of the Year
April 5, 2017
Arizona Congresswoman Kyrsten Sinema was named a 2017 BIO Legislator of the Year
BIO Celebrates Five Years of the JOBS Act
April 5, 2017
Today the Biotechnology Innovation Organization (BIO) celebrates the fifth anniversary of the Jumpstart Our Business Startups (JOBS) Act, which was signed into law on April 5, 2012.  
BIO Brings Worldwide Life Sciences Community Back to San Diego
March 23, 2017
Registration Now Open for International Convention Set for June 19-22
Biotech Leader Testifies Before House Capital Markets Subcommittee
March 22, 2017
Washington, DC (March 22, 2017) – Brian Hahn, Chief Financial Officer of GlycoMimetics, Inc., provided testimony today on behalf of the Biotechnology Innovation Organization (BIO) before the House Subcommittee on Capital Markets and Government…
BIO Announces Plenary Sessions for 2017 World Congress on Industrial Biotechnology
March 22, 2017
BIO has officially released the list of speakers for plenary programs at the 2017 World Congress on Industrial Biotechnology. The sessions will feature executives from the biofuels, household and personal care, and airline industries who…
BIO Praises Reps. Sinema and Hollingsworth for Introducing the Fostering Innovation Act
March 22, 2017
Washington, DC (March 22, 2017) – Today, the Biotechnology Innovation Organization (BIO) applauds Reps. Kyrsten Sinema (D-AZ) and Trey Hollingsworth (R-IN) for introducing the Fostering Innovation Act. The legislation would reduce compliance…
BIO Statement on President’s Budget Proposal
March 16, 2017
Washington, DC (March 16, 2017) – BIO Senior Vice President for Communications Kenneth Lisaius issued the following statement today regarding President Trump’s budget blueprint:“While we are still reviewing today’s budget blueprint, we…
BIO Statement on Confirmation of Ms. Seema Verma
March 13, 2017
BIO congratulates Ms. Seema Verma on her successful confirmation to lead the Centers for Medicare and Medicaid Services (CMS). We look forward to working with her and Secretary Price to advance patient-centric policies that promote affordable access…
BIO President & CEO Greenwood Testifies to House Subcommittee on the Next Farm Bill
March 9, 2017
BIO President & CEO Jim Greenwood today delivered testimony to a House Committee on Agriculture, Subcommittee on Commodity Exchanges, Energy and Credit, Hearing: The Next Farm Bill: Rural Development & Energy Programs.